Blueprint Medicines Corp
BPMCDelisted Jul 18, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001597264
Blueprint Medicines Corp was delisted on Jul 18, 2025; its insiders filed their last Form 4 on Jul 21, 2025; 356 institutions reported holding it in 13F filings for Q2 2025, worth $8.65B in total; Soros Fund Management was the only superinvestor holding it.
13F holders, Q2 2021
Institutional positions in Blueprint Medicines Corp as of Jun 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 281
- +18 vs. Q1 2021
- Shares held
- 58.5M
- −22.8K (0.0%) vs. Q1 2021
- Total value
- $5.14B
- −$547.9M (−9.6%) vs. Q1 2021
- New holders
- 54
- 110 more added
- Sold out
- 36
- 71 more reduced
1 institution that held it in Q1 2021 haven't filed for Q2 2021 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q1 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting BPMC on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 4 | $129 |
| Q1 2026 | 6 | $38.6K |
| Q4 2025 | 8 | $2.57M |
| Q3 2025 | 12 | $2.58M |
| Q2 2025 | 356 | $8.65B |
| Q1 2025 | 353 | $6.12B |
| Q4 2024 | 346 | $5.86B |
| Q3 2024 | 319 | $6.04B |
| Q2 2024 | 305 | $7.15B |
| Q1 2024 | 282 | $6.25B |
| Q4 2023 | 260 | $5.91B |
| Q3 2023 | 220 | $3.25B |
| Q2 2023 | 222 | $4.03B |
| Q1 2023 | 215 | $2.84B |
| Q4 2022 | 223 | $2.74B |
| Q3 2022 | 240 | $4.15B |
| Q2 2022 | 237 | $3.19B |
| Q1 2022 | 248 | $3.82B |
| Q4 2021 | 280 | $6.32B |
| Q3 2021 | 289 | $6.13B |
| Q2 2021 | 281 | $5.14B |
| Q1 2021 | 264 | $5.69B |
Institutions, Q2 2021
Shares, value and share of portfolio for each institution holding Blueprint Medicines Corp; share changes are against Q1 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Mercer Global Advisors Inc | 0 | $0 | 0.00% | −2,914−100.0% | Sold out |
| Bank of Montreal | 0 | $0 | 0.00% | −2,935−100.0% | Sold out |
| Financial Counselors Inc | 0 | $0 | 0.00% | −2,300−100.0% | Sold out |
| Cerity Partners LLC | 0 | $0 | 0.00% | −2,150−100.0% | Sold out |
| CIBC Asset Management Inc | 0 | $0 | 0.00% | −2,075−100.0% | Sold out |
| Golden State Equity Partners | 0 | $0 | 0.00% | −2,070−100.0% | Sold out |
| Pacer Advisors, Inc. | 0 | $0 | 0.00% | −724−100.0% | Sold out |
| Banque Cantonale Vaudoise | 0 | $0 | 0.00% | −605−100.0% | Sold out |
| Bourgeon Capital Management LLC | 0 | $0 | 0.00% | −200−100.0% | Sold out |
| Sowell Financial Services LLC | 0 | $0 | 0.00% | −165−100.0% | Sold out |
| Sonora Investment Management, LLC | 0 | $0 | 0.00% | −95−100.0% | Sold out |
| TCI Wealth Advisors, Inc. | 0 | $0 | 0.00% | −50−100.0% | Sold out |
| Alpha DNA Investment Management LLC | 0 | $0 | 0.00% | −52−100.0% | Sold out |
| Toronto Dominion Bank | 0 | $0 | 0.00% | −24−100.0% | Sold out |
| Raffa Wealth Management, LLC | 0 | $0 | 0.00% | −19−100.0% | Sold out |
| WealthShield Partners, LLC | 0 | $0 | 0.00% | −16−100.0% | Sold out |
| Patriot Financial Group Insurance Agency, LLC | 0 | $0 | 0.00% | −4−100.0% | Sold out |
| Amundi Asset Management US, Inc. | – | – | – | – | Not filed |